CTRI Number |
CTRI/2021/06/034010 [Registered on: 04/06/2021] Trial Registered Prospectively |
Last Modified On: |
02/06/2021 |
Post Graduate Thesis |
No |
Type of Trial |
Observational |
Type of Study
|
Cross Sectional Study |
Study Design |
Other |
Public Title of Study
|
Prevalence of precancerous lesions and its associated factors in Manipur |
Scientific Title of Study
|
Prevalence of oral premalignant lesions (OPML) and its associated factors in north east indian population with special reference to state of Manipur |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Tanya Nandkeoliar |
Designation |
Assistant Professor |
Affiliation |
Regional institute of medical sciences (RIMS) |
Address |
Dental college,room no 3 regional institute of medical sciences (RIMS) lamphelpat
imphal
Imphal West MANIPUR 795004 India |
Phone |
9891725253 |
Fax |
|
Email |
tanya.nandkeoliar@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
DrChAnupriya |
Designation |
Research Assistant |
Affiliation |
Regional institute of medical sciences (RIMS) |
Address |
Dental college,room no 3 regional institute of medical sciences (RIMS) lamphelpat
imphal
Imphal West MANIPUR 795004 India |
Phone |
8731816543 |
Fax |
|
Email |
anupriya3390@gmail.com |
|
Details of Contact Person Public Query
|
Name |
DrChAnupriya |
Designation |
Research Assistant |
Affiliation |
Regional institute of medical sciences (RIMS) |
Address |
Dental college,room no 3 regional institute of medical sciences (RIMS) lamphelpat
imphal
Imphal West MANIPUR 795004 India |
Phone |
8731816543 |
Fax |
|
Email |
anupriya3390@gmail.com |
|
Source of Monetary or Material Support
|
Indian Council of Medical Research
V. Ramalingaswami Bhawan, P.O. Box No. 4911
Ansari Nagar, New Delhi - 110029, India |
|
Primary Sponsor
|
Name |
Indian Council of Medical Research |
Address |
V. Ramalingaswami Bhawan, P.O. Box No. 4911
Ansari Nagar, New Delhi - 110029, India |
Type of Sponsor |
Government funding agency |
|
Details of Secondary Sponsor
|
Name |
Address |
dental collegeRegional institute of Medical sciences |
Dental college,Regional institute of medical sciences,lamphelpat imphal |
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Tanya Nandkeoliar |
Dental College Regional Institute of Medical Sciences (RIMS) |
Room no 1, Department of Oral Medicine and Radiology and Room no 3, Department of Periodontology Imphal West MANIPUR |
9891725253
tanya.nandkeoliar@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
RESEARCH ETHICS BOARD(REB) |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Healthy Human Volunteers |
INDIVIDUALS WITH SIGNS AND SYMPTOMS OF ORAL PREMALIGNANT LESIONS AND CONDITIONS |
|
Intervention / Comparator Agent
|
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
99.00 Year(s) |
Gender |
Both |
Details |
1)individuals residing in Manipur for more than 6months
2)individuals who have the history of tobacco usage, denture wearers or any other irritational factors and/or having signs and symptoms of oral premalignantlesions |
|
ExclusionCriteria |
Details |
1)Individuals less than 18yrs of age
2)Migratory population with not more than 6 months of residence in Manipur
3)Individuals not having history of tobacco usage ,denture wearers,or any other irritational factors
4)Individuals having no sings and symptoms of oral premalignant lesions. |
|
Method of Generating Random Sequence
|
Random Number Table |
Method of Concealment
|
Case Record Numbers |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
the present study is expected to show high prevalence of oral premalignant lesions and conditions . |
7 days |
|
Secondary Outcome
|
Outcome |
TimePoints |
the study may predict the incidence of oral cancers in Manipur |
2 years |
|
Target Sample Size
|
Total Sample Size="2800" Sample Size from India="2800"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
20/06/2021 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
NIL |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form Response - Clinical Study Report
- Who will be able to view these files?
Response - Anyone
- For what types of analyses will this data be available?
Response - Any purpose.
- By what mechanism will data be made available?
Response (Others) - Data will be made available after completion of study ,compilation of results and publication.
- For how long will this data be available start date provided 20-08-2022 and end date provided 22-08-2023?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
Brief Summary
|
A)Background Globally oral cancer is one of the most common cancers and are preceded by oral pre-malignant lesions and conditions such as oral leukoplakia, oral submucous fibrosis (OSMF),and oral erythroplakia which can be easily detected by visual inspection or palpation by health care professionals B)Novelty The proposed study on Oral Premalignant Lesions and conditions would be the first of its kind in the northeast part of India.There is a high rate of mortality and morbidity among individuals and hence it requires to be detected in the premalignant stage to prevent deaths. C)Objectives 1. To estimate the prevalence of oral premalignant lesions. 2. To identify the probable risk factors associated with oral premalignant lesions 3.To suggest preventive measures for oral cancers by early identification of oral premalignant lesions. 2. 4. To prevent malignant transformation of these cases by early detection and to counsel the detected cases for pursuing early treatment. 3. 5.To address the north eastern community for awareness and prevention of cancer through this study. D)Methods: The present study will include case and control group. Individual having history of tobacco usage, denture wearers or any other irritational factors such as malposed teeth impinging on the mucosa and/or having signs and symptoms of OPML and conditions would be included in the case group while those presenting with no signs of OPML and conditions but having the history of tobacco usage, denture wearers, or any other irritational factor, etc would constitute to control group. All individuals will be subjected to a questionnaire and the oralcavity of these participants will be examined. Individuals belonging to the case group would then be subjected to vital staining using toluidine blue dye and biopsy followed by histopathological examination. The data obtained will be subjected to statistical analysis. E) Expected outcome: The present study is expected to show high prevalence of oralpremalignant lesions and hence can be used to predict the incidence of oral cancers. F)Keywords: Oral Premalignant Lesions, Oral Premalignant Conditions, Leukoplakia, Oral Submucous Fibrosis, Tobacco use G)Abbreviations: OPML= Oral Premalignant Lesions, OSMF= Oral Submucous Fibrosis
|